Breaking News Instant updates and real-time market news.

LRCX

Lam Research

$100.19

4.02 (4.18%)

, KLAC

KLA-Tencor

$71.79

0.58 (0.81%)

08:31
10/07/16
10/07
08:31
10/07/16
08:31

Lam Research price target raised to $115 from $105 at Needham

Needham analyst Y. Edwin Mok raised his price target for Lam Research (LRCX) to $115 from $105 after the company and KLA-Tencor (KLAC) terminated the proposed merger after trying to win regulatory approval for almost 12 months, citing a block from the Department of Justice. The analyst sees the news to be "ultimately positive" for Lam Research as management can now focus its effort on its growth strategies. Mok reiterates a Buy rating on Lam Research's shares. He also upgraded KLA-Tencor to Buy this morning.

LRCX

Lam Research

$100.19

4.02 (4.18%)

KLAC

KLA-Tencor

$71.79

0.58 (0.81%)

  • 19

    Oct

  • 18

    Nov

LRCX Lam Research
$100.19

4.02 (4.18%)

10/06/16
RBCM
10/06/16
NO CHANGE
RBCM
Lam Research outlook still positive after merger terminated, says RBC Capital
After Lam Research (LRCX) and KLA-Tencor (KLAC) announced that their merger had been terminated, RBC Capital analyst Amit Daryanani remains upbeat on Lam's outlook as a standalone entity. He expects the company to benefit from strong 3D-NAND spending in 2017, and he keeps a $105 price target and Outperform rating on the stock.
10/06/16
JPMS
10/06/16
NO CHANGE
JPMS
Overweight
JPMorgan recommends buying KLA-Tencor after merger termination
JPMorgan analyst Harlan Sur says that while the terminated merger is "disappointing for both parties," both KLA-Tencor (KLAC) and Lam Research (LRCX) are undervalued on a standalone basis. The analyst expects KLA-Tencor to be "aggressive buyers" of its own stock. He sees share upside to the $85-$90 range and keeps an Overweight rating on the name. Sur recommends buying the shares.
10/06/16
COWN
10/06/16
NO CHANGE
Target $80
COWN
Outperform
Cowen says to buy KLA-Tencor following merger agreement termination
Cowen analyst Timothy Arcuri said the KLA-Tencor (KLAC) merger with Lam Research (LRCX) was called off as expected. He said it was consistent with his assessment and believes Intel (INTC) was the culprit. The companies cited review of options amid recent ant-trust agency feedback. Arcuri said he continues to like Lam Research but prefers KLA-Tencor as he sees it as one of the only semi companies with roughly 30% upside. Arcuri maintained his Outperform rating and $80 price target on KLA-Tencor shares.
10/07/16
10/07/16
UPGRADE
Target $84

Buy
KLA-Tencor upgraded to Buy after merger termination at Needham
As previously reported, Needham analyst Y. Edwin Mok upgraded KLA-Tencor (KLAC) to Buy from Hold, with an $84 price target, after the company and Lam Research (LRCX) terminated their proposed merger. The analyst believes the deal termination has several benefits including more focus on execution of growth strategy, and highlights importance of process control. Additionally, it allows KLA-Tencor to independently pursue M&A to gain market share or expand its TAM, and transition to leaner operating structure going forward, he notes.
KLAC KLA-Tencor
$71.79

0.58 (0.81%)

10/06/16
FBCO
10/06/16
NO CHANGE
Target $85
FBCO
Outperform
KLA-Tencor remains a top pick for 2H 2016, says Credit Suisse
Credit Suisse analyst Farhan Ahmad said merger termination between KLA-Tencor (KLAC) and Lam Research (LRCX) was expected and continues to view KLAC as a top pick for 2H 2016. The analyst said Foundry capex is strong near-term and Gen 5 product growth will drive revenue growth above peers in 2017. Ahmad rates KLA-Tencor an Outperform with an $85 price target.
10/07/16
NEED
10/07/16
UPGRADE
NEED
Buy
KLA-Tencor upgraded to Buy from Hold at Needham

TODAY'S FREE FLY STORIES

AAPL

Apple

$176.19

-0.9 (-0.51%)

06:09
01/17/18
01/17
06:09
01/17/18
06:09
Downgrade
Apple rating change  »

Longbow downgrades Apple…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

SPG

Simon Property

$165.04

-0.47 (-0.28%)

, SBUX

Starbucks

$60.56

0.16 (0.26%)

06:09
01/17/18
01/17
06:09
01/17/18
06:09
Periodicals
Simon, Starbucks reach settlement over Teavana closures, WSJ reports »

Simon Property Group…

SPG

Simon Property

$165.04

-0.47 (-0.28%)

SBUX

Starbucks

$60.56

0.16 (0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 31

    Jan

GOOG

Alphabet

$1,121.76

-0.5 (-0.04%)

, GOOGL

Alphabet Class A

$1,130.70

0.05 (0.00%)

06:08
01/17/18
01/17
06:08
01/17/18
06:08
Hot Stocks
YouTube implements additional requirements for YouTube Partner Program »

In a blog post, Neal…

GOOG

Alphabet

$1,121.76

-0.5 (-0.04%)

GOOGL

Alphabet Class A

$1,130.70

0.05 (0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 23

    Jan

  • 01

    Feb

  • 01

    Feb

  • 07

    Feb

  • 18

    Mar

TPC

Tutor Perini

$27.00

-0.5 (-1.82%)

06:07
01/17/18
01/17
06:07
01/17/18
06:07
Hot Stocks
Tutor Perini subsidiary awarded three new projects for $67M »

Tutor Perini's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORBK

Orbotech

$51.47

0.38 (0.74%)

06:05
01/17/18
01/17
06:05
01/17/18
06:05
Earnings
Orbotech sees FY18 revenue up 12%-14% »

Sees 12-14% revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORBK

Orbotech

$51.47

0.38 (0.74%)

06:04
01/17/18
01/17
06:04
01/17/18
06:04
Earnings
Breaking Earnings news story on Orbotech »

Orbotech sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$4.11

-0.14 (-3.29%)

06:03
01/17/18
01/17
06:03
01/17/18
06:03
Hot Stocks
Amarin initiates clinical development of Vascepa in China »

Amarin's partner…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUVA

NuVasive

$51.99

-1.34 (-2.51%)

06:03
01/17/18
01/17
06:03
01/17/18
06:03
Downgrade
NuVasive rating change  »

Wells Fargo sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$18.21

-0.55 (-2.93%)

06:03
01/17/18
01/17
06:03
01/17/18
06:03
Hot Stocks
GE: Peter Stracar to succeed Mark Hutchinson as President and CEO of GE Europe »

GE announces the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

KL

Kirkland Lake Gold

$16.74

0.62 (3.85%)

06:03
01/17/18
01/17
06:03
01/17/18
06:03
Hot Stocks
Kirkland Lake Gold sees FY18 production growth to over 620,000 ounces »

Highlights of 2018…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORBK

Orbotech

$51.47

0.38 (0.74%)

06:02
01/17/18
01/17
06:02
01/17/18
06:02
Earnings
Orbotech reports preliminary Q4 revenue of about $256M, consensus $250.16M »

Gross margin is expected…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$24.66

-0.75 (-2.95%)

06:01
01/17/18
01/17
06:01
01/17/18
06:01
Periodicals
Twitter sued by TWiT for breach of contract, infringement, TechCrunch reports »

Twitter is being sued by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

SLGN

Silgan Holdings

$29.29

-0.23 (-0.78%)

, CCK

Crown Holdings

$57.79

-0.31 (-0.53%)

05:58
01/17/18
01/17
05:58
01/17/18
05:58
Downgrade
Silgan Holdings, Crown Holdings, Berry Global, Ball Corp. rating change  »

Silgan Holdings…

SLGN

Silgan Holdings

$29.29

-0.23 (-0.78%)

CCK

Crown Holdings

$57.79

-0.31 (-0.53%)

BERY

Berry Global

$59.13

-1.1 (-1.83%)

BLL

Ball Corp.

$38.39

0.49 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 07

    Feb

  • 08

    Feb

ABB

ABB

$28.07

-0.02 (-0.07%)

05:55
01/17/18
01/17
05:55
01/17/18
05:55
Downgrade
ABB rating change  »

ABB downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

IFF

International Flavors

$152.54

-1.16 (-0.75%)

05:54
01/17/18
01/17
05:54
01/17/18
05:54
Upgrade
International Flavors rating change  »

International Flavors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADNT

Adient

$81.91

-0.51 (-0.62%)

05:54
01/17/18
01/17
05:54
01/17/18
05:54
Downgrade
Adient rating change  »

Adient downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

AEP

American Electric

$67.50

0.04 (0.06%)

05:53
01/17/18
01/17
05:53
01/17/18
05:53
Upgrade
American Electric rating change  »

American Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPG

PPG

$116.64

-1.53 (-1.29%)

05:53
01/17/18
01/17
05:53
01/17/18
05:53
Downgrade
PPG rating change  »

PPG downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

NBR

Nabors Industries

$8.23

0.04 (0.49%)

05:52
01/17/18
01/17
05:52
01/17/18
05:52
Downgrade
Nabors Industries rating change  »

Nabors Industries resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

ETH

Ethan Allen

$28.15

-0.5 (-1.75%)

05:52
01/17/18
01/17
05:52
01/17/18
05:52
Downgrade
Ethan Allen rating change  »

Ethan Allen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

QTS

QTS Realty Trust

$52.47

0.82 (1.59%)

05:50
01/17/18
01/17
05:50
01/17/18
05:50
Downgrade
QTS Realty Trust rating change  »

QTS Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LQ

La Quinta

$18.44

-0.03 (-0.16%)

05:50
01/17/18
01/17
05:50
01/17/18
05:50
Upgrade
La Quinta rating change  »

La Quinta upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASND

Ascendis Pharma

$47.60

1.02 (2.19%)

05:50
01/17/18
01/17
05:50
01/17/18
05:50
Recommendations
Ascendis Pharma analyst commentary  »

Ascendis Pharma price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLX

Shell Midstream

$30.74

0.21 (0.69%)

05:50
01/17/18
01/17
05:50
01/17/18
05:50
Downgrade
Shell Midstream rating change  »

Shell Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

ENR

Energizer

$59.11

7.49 (14.51%)

05:47
01/17/18
01/17
05:47
01/17/18
05:47
Downgrade
Energizer rating change  »

Energizer downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 31

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.